SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH H impact

ENDRA Life Sciences Inc. (NDRA) Reports Q3 Net Loss of $1.5M; Merger Awaits Approvals

ENDRA reported a Q3 2026 net loss of $1.5M versus $1.6M in Q3 2025. Its proposed merger with Noble Africa remains subject to stockholder approval, an effective Form S-4 registration statement and Nasdaq listing requirements.Material DetailsContext by AI AnalystThis is a quarterly update during an o…

NDRA

Related stories